Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Virotherapy: Current Trends and Future Prospects for Treatment of Colon and Rectal Malignancies.

Lee CL, Veeramani S, Molouki A, Lim SHE, Thomas W, Chia SL, Yusoff K.

Cancer Invest. 2019 Sep 10:1-22. doi: 10.1080/07357907.2019.1660887. [Epub ahead of print]

PMID:
31502477
2.

An RNA Aptamer-Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients.

Veeramani S, Blackwell SE, Thiel WH, Yang ZZ, Ansell SM, Giangrande PH, Weiner GJ.

Cancer Immunol Res. 2019 Sep;7(9):1511-1522. doi: 10.1158/2326-6066.CIR-18-0821. Epub 2019 Aug 5.

PMID:
31383650
3.

An unusual ECG pattern in restrictive cardimyopathy.

Selvaganesh M, Arul AS, Balasubramanian S, Ganesan N, Naina Mohammed S, Sivakumar GS, Veeramani SR, Jeyasingh P, Sathishkumar S, Selvaraju S.

Indian Heart J. 2015 Jul-Aug;67(4):362-7. doi: 10.1016/j.ihj.2015.05.012. Epub 2015 Jul 8.

4.

Detection of abnormalities in ultrasound lung image using multi-level RVM classification.

Veeramani SK, Muthusamy E.

J Matern Fetal Neonatal Med. 2016;29(11):1844-52. doi: 10.3109/14767058.2015.1064888. Epub 2015 Jul 30.

PMID:
26135771
5.

Complement in monoclonal antibody therapy of cancer.

Rogers LM, Veeramani S, Weiner GJ.

Immunol Res. 2014 Aug;59(1-3):203-10. doi: 10.1007/s12026-014-8542-z. Review.

6.

Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.

Zent CS, Taylor RP, Lindorfer MA, Beum PV, LaPlant B, Wu W, Call TG, Bowen DA, Conte MJ, Frederick LA, Link BK, Blackwell SE, Veeramani S, Baig NA, Viswanatha DS, Weiner GJ, Witzig TE.

Am J Hematol. 2014 Jul;89(7):757-65. doi: 10.1002/ajh.23737. Epub 2014 Apr 26.

7.

Merkel cell carcinoma of the head and neck: challenges in implementing best practice.

Dawe N, Sainsbury D, Veeramani S, Ragbir M, Ahmed OA.

Ann Plast Surg. 2015 Jun;74(6):737-42. doi: 10.1097/SAP.0000000000000016.

PMID:
24401808
8.

p66Shc longevity protein regulates the proliferation of human ovarian cancer cells.

Muniyan S, Chou YW, Tsai TJ, Thomes P, Veeramani S, Benigno BB, Walker LD, McDonald JF, Khan SA, Lin FF, Lele SM, Lin MF.

Mol Carcinog. 2015 Aug;54(8):618-31. doi: 10.1002/mc.22129. Epub 2014 Jan 7.

9.

Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.

Veeramani S, Chou YW, Lin FC, Muniyan S, Lin FF, Kumar S, Xie Y, Lele SM, Tu Y, Lin MF.

Free Radic Biol Med. 2012 Jul 1;53(1):95-108. doi: 10.1016/j.freeradbiomed.2012.03.024. Epub 2012 Apr 16.

10.

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism.

Veeramani S, Wang SY, Dahle C, Blackwell S, Jacobus L, Knutson T, Button A, Link BK, Weiner GJ.

Blood. 2011 Sep 22;118(12):3347-9. doi: 10.1182/blood-2011-05-351411. Epub 2011 Jul 18.

11.

Shell-bound iron dependant nitric oxide synthesis in encysted Artemia parthenogenetica embryos during hydrogen peroxide exposure.

Veeramani S, Baskaralingam V.

Biometals. 2011 Dec;24(6):1035-44. doi: 10.1007/s10534-011-9462-1. Epub 2011 May 22.

PMID:
21604169
12.

Management of cutaneous metastases using electrochemotherapy.

Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessell G, Humphreys AC, Bond JE, Muir T, Gehl J.

Acta Oncol. 2011 Jun;50(5):621-9. doi: 10.3109/0284186X.2011.573626.

13.

Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.

Chuang TD, Chen SJ, Lin FF, Veeramani S, Kumar S, Batra SK, Tu Y, Lin MF.

J Biol Chem. 2010 Jul 30;285(31):23598-606. doi: 10.1074/jbc.M109.098301. Epub 2010 May 24.

14.

p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.

Rajendran M, Thomes P, Zhang L, Veeramani S, Lin MF.

Cancer Metastasis Rev. 2010 Mar;29(1):207-22. doi: 10.1007/s10555-010-9213-8. Review.

15.

Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model.

Wang SY, Veeramani S, Racila E, Cagley J, Fritzinger DC, Vogel CW, St John W, Weiner GJ.

Blood. 2009 Dec 17;114(26):5322-30. doi: 10.1182/blood-2009-01-200469. Epub 2009 Oct 5.

16.

Revisiting histidine-dependent acid phosphatases: a distinct group of tyrosine phosphatases.

Veeramani S, Lee MS, Lin MF.

Trends Biochem Sci. 2009 Jun;34(6):273-8. doi: 10.1016/j.tibs.2009.03.002. Epub 2009 May 19.

17.

A novel role of Shc adaptor proteins in steroid hormone-regulated cancers.

Alam SM, Rajendran M, Ouyang S, Veeramani S, Zhang L, Lin MF.

Endocr Relat Cancer. 2009 Mar;16(1):1-16. doi: 10.1677/ERC-08-0179. Epub 2008 Nov 11. Review.

18.

Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells.

Veeramani S, Yuan TC, Lin FF, Lin MF.

Oncogene. 2008 Aug 28;27(37):5057-68. doi: 10.1038/onc.2008.143. Epub 2008 May 26.

19.

Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.

Yuan TC, Veeramani S, Lin MF.

Endocr Relat Cancer. 2007 Sep;14(3):531-47. Review.

PMID:
17914087
20.

ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells.

Yuan TC, Lin FF, Veeramani S, Chen SJ, Earp HS 3rd, Lin MF.

Oncogene. 2007 Nov 29;26(54):7552-9. Epub 2007 Jun 11.

PMID:
17563746
21.

Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis.

Donaldson P, Veeramani S, Baragiotta A, Floreani A, Venturi C, Pearce S, Wilson V, Jones D, James O, Taylor J, Newton J, Bassendine M.

Clin Gastroenterol Hepatol. 2007 Jun;5(6):755-60. Epub 2007 May 7.

PMID:
17482523
22.

Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.

Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF.

Endocr Relat Cancer. 2006 Mar;13(1):151-67.

PMID:
16601285
23.

Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.

Veeramani S, Yuan TC, Chen SJ, Lin FF, Petersen JE, Shaheduzzaman S, Srivastava S, MacDonald RG, Lin MF.

Endocr Relat Cancer. 2005 Dec;12(4):805-22. Review.

PMID:
16322323
24.

Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells.

Veeramani S, Igawa T, Yuan TC, Lin FF, Lee MS, Lin JS, Johansson SL, Lin MF.

Oncogene. 2005 Nov 3;24(48):7203-12.

PMID:
16170380
25.

Molecular mass determination of polyamic acid ionic salt by size-exclusion chromatography.

Krishnan PS, Veeramani S, Vora RH, Chung TS, Uchimura S, Sugitani H.

J Chromatogr A. 2002 Nov 22;977(2):207-12.

PMID:
12456110

Supplemental Content

Loading ...
Support Center